Successful treatment of neovascular age-related macular degeneration following single bevacizumab failure using aflibercept in a vitrectomized eye

Paul Hahn Duke Eye Center, Duke University Medical Center, Durham, NC, USA Abstract: Intravitreal anti-vascular endothelial growth factor (VEGF) pharmacotherapy in vitrectomized eyes remains a challenge due to the reduced half-life of these agents. Aflibercept may have stronger binding activity a...

Full description

Saved in:
Bibliographic Details
Main Author: Hahn P
Format: article
Language:EN
Published: Dove Medical Press 2014
Subjects:
Online Access:https://doaj.org/article/ac166e2228324f9db5ad66860dfbfcda
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items